Carlsmed Inc. raised $100.5 million in its US initial public offering, pricing shares in the medical technology company within a marketed range.
The firm, which uses AI to personalize spine surgery, sold 6.7 million shares at $15 apiece, according to terms of the deal seen by Bloomberg News. The company had offered shares for $14 to $16 each, according to an earlier US Securities and Exchange Commission filing.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.